A Trial‐Level Benefit–Toxicity Mapping Framework for Adjuvant Therapy in Renal Cell Carcinoma: A Focused Review

Masanao Shinohara, Takuma Narita, Shingo Hatakeyama
International Journal of Urology · Wiley · 2026-10-29 · DOI: 10.1111/iju.70689

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles